Brian Duggan

567 total citations
26 papers, 414 citations indexed

About

Brian Duggan is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brian Duggan has authored 26 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brian Duggan's work include Bladder and Urothelial Cancer Treatments (8 papers), Cancer Research and Treatments (6 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). Brian Duggan is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Cancer Research and Treatments (6 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). Brian Duggan collaborates with scholars based in United Kingdom, Ireland and United States. Brian Duggan's co-authors include Kate E. Williamson, Samuel Johnston, Patrick F. Keane, Trevor Thompson, Michael Young, Vincent Koo, John D. Kelly, Chris Watson, Neil H. Anderson and Karen D. McCloskey and has published in prestigious journals such as PLoS ONE, Cancer and The Journal of Urology.

In The Last Decade

Brian Duggan

25 papers receiving 403 citations

Peers

Brian Duggan

SURGE

MB

PRM

PPCH

UROLO

Alex S. Baras United States

Keefe Murphy Ireland

Octavian Sabin Tătaru Romania

Nicola Antonio di Meo Italy

H. Ballentine Carter United States

Mark A. Perlmutter United States

Claire Cox United Kingdom

Şeyda Karaveli Türkiye

Xiongjun Ye China

Alex S. Baras United States

Brian Duggan

187 ×1.1

SURGE

214 ×1.4

MB

203 ×1.8

PRM

18 ×0.3

PPCH

44 ×0.6

UROLO

Citations per year, relative to Brian Duggan Brian Duggan (= 1×) peers Alex S. Baras

Countries citing papers authored by Brian Duggan

Since Specialization

Citations

This map shows the geographic impact of Brian Duggan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Duggan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Duggan more than expected).

Fields of papers citing papers by Brian Duggan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Duggan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Duggan. The network helps show where Brian Duggan may publish in the future.

Co-authorship network of co-authors of Brian Duggan

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Duggan. A scholar is included among the top collaborators of Brian Duggan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Duggan. Brian Duggan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Duggan, Brian, Declan O’Rourke, Neil Anderson, et al.. (2022). Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific. Frontiers in Oncology. 12. 1009014–1009014. 4 indexed citations

2.

Tonry, Claire, Mark W. Ruddock, Brian Duggan, et al.. (2022). Clinical features and predictive biomarkers for bladder cancer in patients with type 2 diabetes presenting with haematuria. Diabetes/Metabolism Research and Reviews. 38(6). e3546–e3546. 2 indexed citations

3.

Hennessey, Derek, et al.. (2018). Compliance in patients with dietary hyperoxaluria: A cohort study and systematic review. Asian journal of urology. 6(2). 200–207. 3 indexed citations

4.

Sutton, Andrew, John Lamont, Richard Evans, et al.. (2018). An early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancer. PLoS ONE. 13(8). e0202796–e0202796. 14 indexed citations

5.

Wolfe, Robert E., et al.. (2015). USGCRP Global Change Information System Support for the SOCCR-2. AGUFM. 2015. 1 indexed citations

6.

Duggan, Brian, et al.. (2015). Normalizing Resource Identifiers using Lexicons in the Global Change Information System.. 2 indexed citations

7.

Wolfe, Robert E., et al.. (2015). Providing provenance to instruments through the US global change information system. 143–145. 1 indexed citations

8.

Marcet‐Palacios, Marcelo, C. Ewen, Emily Pittman, et al.. (2014). Design and characterization of a novel human Granzyme B inhibitor. Protein Engineering Design and Selection. 28(1). 9–17. 8 indexed citations

9.

Emmert‐Streib, Frank, Ricardo De Matos Simoes, Brian Duggan, et al.. (2013). Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker data. BMC Medicine. 11(1). 12–12. 11 indexed citations

10.

Ruddock, Mark W., Michael Stevenson, Joe M. O’Sullivan, et al.. (2011). The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria. Cancer. 118(10). 2641–2650. 35 indexed citations

11.

Koo, Vincent, Michael Young, Trevor Thompson, & Brian Duggan. (2011). Cost‐effectiveness and efficiency of shockwave lithotripsy vs flexible ureteroscopic holmium:yttrium‐aluminium‐garnet laser lithotripsy in the treatment of lower pole renal calculi. British Journal of Urology. 108(11). 1913–1916. 55 indexed citations

12.

Johnston, Louise, Rebecca M. Cunningham, Hugh O’Kane, et al.. (2010). Morphological Expression of KIT Positive Interstitial Cells of Cajal in Human Bladder. The Journal of Urology. 184(1). 370–377. 59 indexed citations

13.

Thwaini, Ali, et al.. (2010). Urologists versus radiologists made PCNL tracts: the UK experience. Urological Research. 39(3). 217–221. 15 indexed citations

14.

Tilmes, Curt, et al.. (2010). OMI Near Real Time data processing. 6. 586–588. 2 indexed citations

15.

Stevenson, Mark A., Joe M. O’Sullivan, Brian Duggan, et al.. (2009). 48LBA Algorithmic classifiers to diagnose bladder cancer. European Journal of Cancer Supplements. 7(3). 21–21.

16.

Johnston, Samuel, et al.. (2005). Antisense oligonucleotides in the treatment of bladder cancer. Expert Opinion on Biological Therapy. 5(1). 67–77. 8 indexed citations

17.

Duggan, Brian & Kate E. Williamson. (2004). Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?). Current Opinion in Urology. 14(5). 277–286. 23 indexed citations

18.

Duggan, Brian, Finbarr E. Cotter, John D. Kelly, et al.. (2001). Antisense Bcl–2 Oligonucleotide Uptake in Human Transitional Cell Carcinoma. European Urology. 40(6). 685–695. 12 indexed citations

19.

Duggan, Brian, Perry Maxwell, John D. Kelly, et al.. (2001). THE EFFECT OF ANTISENSE BCL-2 OLIGONUCLEOTIDES ON BCL-2 PROTEIN EXPRESSION AND APOPTOSIS IN HUMAN BLADDER TRANSITIONAL CELL CARCINOMA. The Journal of Urology. 166(3). 1098–1105. 41 indexed citations

20.

Duggan, Brian, Perry Maxwell, John D. Kelly, et al.. (2001). THE EFFECT OF ANTISENSE BCL-2 OLIGONUCLEOTIDES ON BCL-2 PROTEIN EXPRESSION AND APOPTOSIS IN HUMAN BLADDER TRANSITIONAL CELL CARCINOMA. The Journal of Urology. 1098–1105. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact